News
TEVA
31.05
-2.20%
-0.70
The 3 Best Stocks to Invest $1,000 in Right Now
The Motley Fool · 23h ago
Corcept's Korlym Drives its 2025 Revenue Surge: What's Ahead?
NASDAQ · 2d ago
J.P. Morgan Sticks to Their Buy Rating for Teva Pharmaceutical (TEVA)
TipRanks · 2d ago
Zacks Industry Outlook Highlights Teva Pharmaceuticals, Sandoz and Dr. Reddy's
NASDAQ · 2d ago
Teva Blackstone Duvakitug Deal Tests Growth Story And Concentration Risk
Simply Wall St · 2d ago
Forget Teva: This Dividend Top Dog Is the Real Value Buy Today
The Motley Fool · 2d ago
3 Generic Drug Stocks to Watch Despite Industry Headwinds
NASDAQ · 3d ago
Teva Pharmaceuticals Price Target Raised to $41.00/Share From $40.00 by Piper Sandler
Dow Jones · 3d ago
Piper Sandler Reiterates Overweight on Teva Pharmaceutical Indus, Raises Price Target to $41
Benzinga · 3d ago
Analysts Are Bullish on These Healthcare Stocks: Teva Pharmaceutical (TEVA), Aquestive Therapeutics (AQST)
TipRanks · 3d ago
Billionaire Stanley Druckenmiller Dumped 2 of His Top Performers -- Teva and Taiwan Semiconductor -- and Made This Sector-Based ETF His Fund's New No. 2 Holding
The Motley Fool · 3d ago
Teva: Blackstone Life Sciences To Provide $400 Mln To Support Development Of Duvakitug
NASDAQ · 3d ago
BRIEF-Teva And Blackstone Life Sciences Announce $400 Million Strategic Growth Capital Agreement To Advance Duvakitug
Reuters · 3d ago
Teva gains $400M investment from Blackstone Life Sciences to advance duvakitug
Seeking Alpha · 3d ago
Blackstone Gives Teva $400M to Develop Inflammatory Bowel Disease Treatment
Dow Jones · 3d ago
Blackstone Life Sciences and Teva Sign $400 Million Funding Deal for Duvakitug Development
Reuters · 3d ago
Teva and Blackstone Life Sciences strike $400 million duvakitug development deal
Reuters · 3d ago
Teva, Blackstone announce $400M strategic funding agreement for duvakitug
TipRanks · 3d ago
Teva Pharmaceutical Industries' Teva Pharmaceuticals And Funds Managed By Blackstone Life Sciences Reveal A $400M Strategic Funding Agreement Spread Across Four Years To Support The Continued Clinical Development Of Duvakitug
Benzinga · 3d ago
TEVA AND BLACKSTONE LIFE SCIENCES ANNOUNCE $400 MILLION STRATEGIC GROWTH CAPITAL AGREEMENT TO ADVANCE DUVAKITUG
Reuters · 3d ago
More
Webull provides a variety of real-time TEVA stock news. You can receive the latest news about Teva Pharm through multiple platforms. This information may help you make smarter investment decisions.
About TEVA
Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.